Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study.

Thamer A AlmangourLeen GhonemAhmad AljabriAlya AlruwailiMohammed Al MusawaNader DamfuMesfer S AlmalkiMajda AlattasHossam AbedDoaa NaeemNawaf AlmalkiAbdullah A Alhifany

Published in: Infection and drug resistance (2022)

CAZ-AVI is associated with higher rate of clinical cure and lower rate of AKI compared to colistin. Our findings support the preferential use of CAZ-AVI over colistin-based regimen for treating these infections.

Keyphrases

gram negative
klebsiella pneumoniae
multidrug resistant
acinetobacter baumannii
escherichia coli
pseudomonas aeruginosa
drug resistant
acute kidney injury
clinical trial
double blind
smoking cessation